Literature DB >> 3710058

Carnitine transport in human intestinal biopsy specimens. Demonstration of an active transport system.

J W Hamilton, B U Li, A L Shug, W A Olsen.   

Abstract

Although carnitine is present in a variety of foods, the mechanism of its absorption has not been previously studied in humans. We investigated the absorption of carnitine by studying uptake into human intestinal mucosal biopsy specimens. We found evidence of active transport in the duodenum and ileum, but not in the colon. We demonstrated that intracellular concentrations exceeded concentrations in the incubation media at steady states and that uptake against a concentration gradient was abolished by anoxia and by replacement of sodium ion with potassium. Studies of initial rate of uptake over a range of concentrations revealed a curve consistent with a two-component system: a saturable system with a KT of 558 microM and a linear component probably representing passive diffusion. Addition of D-carnitine and L-acetylcarnitine resulted in diminished uptake of L-carnitine, suggesting that these substrates utilize the same transport mechanism. These studies demonstrate the presence of an active intestinal transport system for L-carnitine in human intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3710058     DOI: 10.1016/0016-5085(86)90432-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

Review 1.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

2.  Effect of codeine and loperamide on upper intestinal transit and absorption in normal subjects and patients with postvagotomy diarrhoea.

Authors:  J D O'Brien; D G Thompson; A McIntyre; W R Burnham; E Walker
Journal:  Gut       Date:  1988-03       Impact factor: 23.059

3.  Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet.

Authors:  Judit Bene; Katalin Komlósi; Beáta Gasztonyi; Márk Juhász; Zsolt Tulassay; Béla Melegh
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

4.  Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis.

Authors:  Giuseppe D'Argenio; Orsolina Petillo; Sabrina Margarucci; Angela Torpedine; Anna Calarco; Angela Koverech; Angelo Boccia; Giovanni Paolella; Gianfranco Peluso
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

5.  Developmental maturation and segmental distribution of rat small intestinal L-carnitine uptake.

Authors:  P García-Miranda; J M Durán; M J Peral; A A Ilundáin
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

Review 6.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

7.  Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.

Authors:  W A Gahl; I Bernardini; M Dalakas; W B Rizzo; G S Harper; J M Hoeg; O Hurko; J Bernar
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

8.  Serum carnitine concentrations in coeliac disease.

Authors:  A Lerner; N Gruener; T C Iancu
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

9.  Uptake of L-carnitine by rat jejunal brush border microvillous membrane vesicles. Evidence of passive diffusion.

Authors:  B U Li; P M Bummer; J W Hamilton; H Gudjonsson; G Zografi; W A Olsen
Journal:  Dig Dis Sci       Date:  1990-03       Impact factor: 3.199

10.  Protein ingestion acutely inhibits insulin-stimulated muscle carnitine uptake in healthy young men.

Authors:  Chris E Shannon; Aline V Nixon; Paul L Greenhaff; Francis B Stephens
Journal:  Am J Clin Nutr       Date:  2015-12-16       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.